Sandoz Recalls Losartan Potassium, Ezetimibe Prescription Bottles

Sandoz has voluntarily recalled losartan potassium and ezetimibe in prescription drug bottles in the U.S. due to failure to meet child-resistant closure requirements. There are no quality or safety issues with medicines for their intended use.

This recall involves bottles of prescription medications Losartan Potassium and Ezetimibe from Sandoz with certain lot numbers.  The recalled bottles have "Sandoz," the name of the medication, dosage, and NDC on the front of the bottle labels and the lot number and expiration date on the side of the bottle labels.

Consumers should immediately secure the medications to keep them out of the sight and reach of children. Once the medication is secured, consumers can continue to use the medication as directed.

Consumers or pharmacies who have impacted prescription drug bottles with these NDC numbers should contact Sandoz at 1-800-525-8747 option # for free replacement child-resistant bottle caps.

The prescription drug packaging is not child resistant as required by the Poison Prevention Packaging Act, posing a poisoning risk if swallowed by children.

-----------------------------------------------------------------------
Editor's Note:

For any copyright disputes involving the content, 

please email: Julia.Zhang@ubmsinoexpo.com to delete.